These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8821592)

  • 1. Mechanisms of hyperproduction of TEM-1 beta-lactamase by clinical isolates of Escherichia coli.
    Wu PJ; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Dec; 36(6):927-39. PubMed ID: 8821592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism and stability of hyperproduction of the extended-spectrum beta-lactamase SHV-5 in Klebsiella pneumoniae.
    Xiang X; Shannon K; French G
    J Antimicrob Chemother; 1997 Oct; 40(4):525-32. PubMed ID: 9372422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
    Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
    J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15.
    Shannon K; Williams H; King A; Phillips I
    FEMS Microbiol Lett; 1990 Feb; 55(3):319-23. PubMed ID: 2182386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased detection of extended spectrum beta-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry.
    Dierikx C; van Essen-Zandbergen A; Veldman K; Smith H; Mevius D
    Vet Microbiol; 2010 Oct; 145(3-4):273-8. PubMed ID: 20395076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissemination of Escherichia coli producing AmpC-type beta-lactamase (CMY-11) in Korea.
    Kim JY; Song JS; Bak SH; Cho YE; Kim DW; Jeong SH; Park YM; Lee KJ; Lee SH
    Int J Antimicrob Agents; 2004 Oct; 24(4):320-6. PubMed ID: 15380255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
    Seetulsingh PS; Hall LM; Livermore DM
    J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and molecular characterization of CTX-M β-lactamase-producing Escherichia coli isolated from healthy swine and cattle.
    Tamang MD; Nam HM; Kim SR; Chae MH; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2013 Jan; 10(1):13-20. PubMed ID: 23210923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.
    Briñas L; Moreno MA; Teshager T; Zarazaga M; Sáenz Y; Porrero C; Dominguez L; Torres C
    Microb Drug Resist; 2003; 9(2):201-9. PubMed ID: 12820806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rarity of transferable beta-lactamase production by Klebsiella species.
    Leung M; Shannon K; French G
    J Antimicrob Chemother; 1997 Jun; 39(6):737-45. PubMed ID: 9222043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of plasmid copy number and runaway plasmid replication on overproduction and excretion of beta-lactamase from Escherichia coli.
    Togna AP; Shuler ML; Wilson DB
    Biotechnol Prog; 1993; 9(1):31-9. PubMed ID: 7763410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Lactamases in amoxicillin-clavulanate-resistant Escherichia coli strains isolated from a Chinese tertiary hospital.
    Ding J; Ma X; Chen Z; Feng K
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):532-3. PubMed ID: 23726651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferable hyperproduction of TEM-1 beta-lactamase in Shigella flexneri due to a point mutation in the pribnow box.
    Siu LK; Ho PL; Yuen KY; Wong SS; Chau PY
    Antimicrob Agents Chemother; 1997 Feb; 41(2):468-70. PubMed ID: 9021210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
    Beceiro A; Maharjan S; Gaulton T; Doumith M; Soares NC; Dhanji H; Warner M; Doyle M; Hickey M; Downie G; Bou G; Livermore DM; Woodford N
    J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequences of small blaTEM-encoding plasmids in Haemophilus influenzae and description of variants falsely negative for blaTEM by PCR.
    Tristram SG; Franks LR; Harvey GL
    J Antimicrob Chemother; 2012 Nov; 67(11):2621-5. PubMed ID: 22782486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC.
    Caroff N; Espaze E; Gautreau D; Richet H; Reynaud A
    J Antimicrob Chemother; 2000 Jun; 45(6):783-8. PubMed ID: 10837430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.